Cargando…
Macrophage Migration Inhibitory Factor (MIF) Drives Murine Psoriasiform Dermatitis
The immunomodulator Macrophage Migration Inhibitory Factor (MIF) exerts pleiotropic immunomodulatory activities and has been implicated in the pathogenesis of diverse inflammatory diseases. Expression levels of MIF are also significantly elevated in the skin and serum of psoriasis patients, but the...
Autores principales: | Bezdek, Siegfried, Leng, Lin, Busch, Hauke, Mousavi, Sadegh, Rades, Dirk, Dahlke, Markus, Zillikens, Detlef, Bucala, Richard, Sadik, Christian D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176003/ https://www.ncbi.nlm.nih.gov/pubmed/30333830 http://dx.doi.org/10.3389/fimmu.2018.02262 |
Ejemplares similares
-
Immunological Memory in Imiquimod-Induced Murine Model of Psoriasiform Dermatitis
por: Fenix, Kevin, et al.
Publicado: (2020) -
1677 Macrophage migration inhibitory factor (MIF) promotes clearance of pneumococcal colonization
por: Das, Rituparna, et al.
Publicado: (2014) -
GM-CSF in murine psoriasiform dermatitis: Redundant and pathogenic roles uncovered by antibody-induced neutralization and genetic deficiency
por: Scholz, Tatjana, et al.
Publicado: (2017) -
The macrophage migration inhibitory factor (MIF)-homologue D-dopachrome tautomerase is a therapeutic target in a murine melanoma model
por: Kobold, Sebastian, et al.
Publicado: (2013) -
Oral administration of the selective GPR120/FFA4 agonist compound A is not effective in alleviating tissue inflammation in mouse models of prototypical autoimmune diseases
por: Wannick, Melanie, et al.
Publicado: (2018)